Alerts will be sent to your verified email
Verify EmailJBCHEPHARM
JB Chem & Pharma
|
Akums Drugs & Pharmaceuticals
|
Ipca Laboratories
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
Number of ANDA's Filed in USA
|
19.0 . | n/a | 43.0 . |
Number of ANDA's Approved By USFDA
|
17.0 . | n/a | 21.0 . |
Domestic Sales Growth - YoY
|
9.4 % | n/a | 5.9 % |
R&D as a % of Total Sales
|
1.16 % | 2.69 % | 2.64 % |
Financials
|
|||
5 yr Average ROE
|
19.44 % | -1.49 % | 14.77 % |
5yr average Equity Multiplier
|
1.5 | 3.89 | 1.47 |
5yr Average Asset Turnover Ratio
|
0.79 | 1.2 | 0.79 |
5yr Avg Net Profit Margin
|
16.41 % | 0.42 % | 12.85 % |
Price to Book
|
9.77 | 18.47 | 5.92 |
P/E
|
48.63 | 0.0 | 64.99 |
5yr Avg Cash Conversion Cycle
|
19.31 Days | 54.08 Days | 62.7 Days |
Inventory Days
|
51.72 Days | 59.02 Days | 101.09 Days |
Days Receivable
|
63.93 Days | 73.33 Days | 63.37 Days |
Days Payable
|
85.63 Days | 80.99 Days | 112.44 Days |
5yr Average Interest Coverage Ratio
|
65.09 | 5.39 | 55.69 |
5yr Avg ROCE
|
23.24 % | 6.35 % | 18.16 % |
5yr Avg Operating Profit Margin
|
26.07 % | 6.44 % | 22.14 % |
5 yr average Debt to Equity
|
0.08 | 0.47 | 0.16 |
5yr CAGR Net Profit
|
15.23 % | n/a | -2.03 % |
5yr Average Return on Assets
|
13.06 % | 0.52 % | 10.46 % |
Shareholdings
|
|||
Promoter Holding
|
53.77 % | n/a | 46.3 % |
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-2.14 % | n/a | 0.01 % |
Change in Mutual Fund Holding (3 Yrs)
|
4.49 % | n/a | 7.03 % |
JB Chem & Pharma
|
Akums Drugs & Pharmaceuticals
|
Ipca Laboratories
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Customer Wise Break-Up
|
Customer Wise Break-Up
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|